Treatment to reverse mydriasis caused by ophthalmic adrenergic or anticholinergic agent

Pharmacologically induced mydriasis is an iatrogenic state characterized by prolonged pupillary dilation resulting from the topical administration of ophthalmic adrenergic agonists, anticholinergic agents, or their combination during diagnostic eye examinations or surgical procedures Reversal focuses on counteracting this drug-induced pupillary dilation to hasten the return of baseline pupil diameter and resolve accompanying visual disturbances

Pharmacologically induced mydriasis is an iatrogenic state characterized by prolonged pupillary dilation resulting from the topical administration of ophthalmic adrenergic agonists, anticholinergic agents, or their combination during diagnostic eye examinations or surgical procedures Affecting the ocular system in pediatric and adult patients, the condition arises from active stimulation of the iris dilator muscle, paralysis of the iris sphincter pupillae, or both mechanisms simultaneously Clini...

Affecting the ocular system in pediatric and adult patients, the condition arises from active stimulation of the iris dilator muscle, paralysis of the iris sphincter pupillae, or both mechanisms simultaneously

Clinically, affected individuals experience an enlarged pupillary aperture that impairs light regulation, typically presenting with photophobia, reduced depth of field, and transient visual blurring that can persist for up to 24 hours

Reversal focuses on counteracting this drug-induced pupillary dilation to hasten the return of baseline pupil diameter and resolve accompanying visual disturbances